Osteotropic β-cyclodextrin for local bone regeneration

This publication has 26 references indexed in Scilit:

• Alendronate Has an Anabolic Effect on Bone Through the Differentiation of Mesenchymal Stem Cells
  Journal of Bone and Mineral Research, 2007
• Sugammadex: A Novel Agent for the Reversal of Neuromuscular Blockade
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
• Craniofacial Bone Tissue Engineering
  Dental Clinics of North America, 2006
• Local Simvastatin Effects on Mandibular Bone Growth and Inflammation
  Journal of Periodontology, 2005
• Bone Morphogenic Protein Science and Studies
  Journal of Orthopaedic Trauma, 2005
• First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide
  Anesthesiology, 2005
• Bisphosphonates: A review of their pharmacokinetic properties
  Bone, 1996
• Local stimulation of new bone formation by prostaglandin E1: Quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets
  Bone, 1993
• Improvement of Stability and Dissolution of Prostaglandin E1 by Maltosyl-.BETA.-cyclodextrin in Lyophilized Formulation.
  Chemical and Pharmaceutical Bulletin, 1992
• Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-.BETA.-cyclodextrins.
  Chemical and Pharmaceutical Bulletin, 1984